spacer
home > ebr > summer 2002 > a case for alternative financing in biomedical companies industry dynamics
PUBLICATIONS
European Biopharmaceutical Review

A Case for Alternative Financing in Biomedical Companies INDUSTRY DYNAMICS

The biomedical sector is gripped by the imminent threat, or promise, of consolidation. Many company founders and investors may lose their investments and the efforts of the last five years without a flexible response to the strains imposed on their current business plans. For some, the only alternative will be to restructure their business strategy and to adjust to the needs of the changing market conditions.In such challenging times, seeking an alternative approach to the traditional financing of biomedical businesses may be prudent. This article aims to review some of the better known choices for companies at each stage of development, and to introduce a new alternative approach which may be of vital interest in the future, particularly for those at a later stage of development.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Martin Austin, Director of European Operations, Paul Royalty Funds at Paul Capital Partners

Martin Austin is Director of European Operations at Paul Royalty Funds. Martin joined Paul Capital Partners in 2000 to lead the European activities for the Royalty Acquisition Fund in sourcing and due diligence. In 1988 he co-founded Machine Intelligence Technologies in the UK following over 25 years in the pharmaceutical industry with G. D. Searle and Synthйlabo, and as a Consultant with Marketing Improvements Ltd.
He then went on to found MHIG Ltd - a UK/German joint venture market research consultancy. In 1996 he joined F-Hoffmann-La Roche in Basel, Switzerland, becoming global Head of Business Development for Pharmaceuticals. Martin has an Advanced Certificate in Education from Reading University and a BA from the UK Open University.

spacer
Martin Austin
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Kaye now also offers Cold Chain Monitoring Solution Monitor your sensitive product shipment on your smartphone

Pforzheim, Germany May 2020; Kaye is pleased to announce Kaye Log Cold Chain Monitoring during Transportation.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement